(Q35540355)

8 August 2017

1 reference

title

Cerebrometabolic abnormalities in Alzheimer's disease (English)

1 reference

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

12 March 2024

author name string

John P. Blass

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503009

12 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14503009

12 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1179/016164103101201995

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

12 March 2024

published in

Neurological Research

1 reference

8 August 2017

volume

25

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

556-566

1 reference

Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Cerebrometabolic aspects of delirium in relationship to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Clinical application of positron emission tomography for diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Lipid peroxidation in aging brain and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

How important is oxidative damage? Lessons from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid beta-peptide (1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Redox properties of Met(35) in neurotoxic beta-amyloid peptide. A molecular modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Inactivation of the 2-oxo acid dehydrogenase complexes upon generation of intrinsic radical species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of alpha-ketoglutarate dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Modulation byDLST of the genetic risk of Alzheimer's disease in a very elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Mitochondrial free radical production and aging in mammals and birds

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Disruption of the potential across the synaptosomal plasma membrane and mitochondria by neurotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Transglutaminases: crosslinking enzymes with pleiotropic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Isolation and characterization of brain-specific transglutaminases from rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Brain dysfunction in mild to moderate hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Organelle-specific initiation of cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Selective sensitivity of synaptosomal membrane function to cerebral cortical hypoxia in newborn piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Thiamine and Alzheimer's disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

A trial of thiamine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Treatment of Alzheimer's disease by transposition of the omentum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Role of mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201995

The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome.

21 January 2018

16

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Synthesis and degradation of cytochrome oxidase subunit mRNAs in neurons: differential bigenomic regulation by neuronal activity

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Mitochondrial abnormalities in Alzheimer's disease.

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Nonneural Markers in Alzheimer Disease

12 March 2024

27

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage

12 March 2024

45

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-L-cysteine

12 March 2024

57

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

12 March 2024

61

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Delirium, a syndrome of cerebral insufficiency

12 March 2024

70

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxia

12 March 2024

72

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation

12 March 2024

77

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

Expression of 'Alzheimer Antigens' in Cultured Skin Fibroblasts

12 March 2024

80

1 reference

https://api.crossref.org/works/10.1179/016164103101201995

12 March 2024

Identifiers

1 reference

8 August 2017

1 reference